AmDerma
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, AmDerma sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
AmDerma: 6 sponsored US clinical trials, none currently recruiting.
AmDerma sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 2 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Athlete's Foot, with 2 trials.
Upper-quartile sponsor footprint
AmDerma sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
NCT03210740
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
NCT01938599
Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years
NCT01696799
Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
NCT01358240
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
NCT01353976
A Study of Econazole Foam 1% in Athlete's Foot
NCT00768599
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 2 |
Therapeutic Areas
How the AmDerma early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase mix: 2 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Athlete's Foot (2 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
AmDerma: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
AmDerma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this AmDerma page
6 registered trials is a research-attention snapshot, not an endorsement of AmDerma or any single study.
- None of AmDerma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Athlete's Foot is the condition AmDerma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Athlete's Foot trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AmDerma pipeline card: 6 registered trials from official public datasets.Report a data error.